SYBX Synlogic: Rentabilitas operasi

Logo korporat perusahaan Synlogic Corp (SYBX)

Synlogic, Inc. (SYBX) applies an engineering approach to biology, programming living cells via robotic systems. Automated dosing and software data validation optimize laboratory tests. The core operating margin illustrates the efficiency of these processes, while the 0.00 metric confirms the current profitability level. The company creates synthetic bacteria to break down toxins in the gut, focusing on therapies for rare metabolic disorders.

Synlogic, Inc. (SYBX): Rentabilitas kegiatan operasi saka 04.07.2022 nganti 24.01.2026

Rincian analitis perusahaan Synlogic Corp (SYBX)

- rega lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:SYBX, Synlogic, Inc.
Barang utama Synlogic Inc.

Operating margin determines cost management efficiency by measuring the portion of revenue that transforms into operating profit before taxes and interest. An analysis of the EBIT level confirms the terminal state of Synlogic, Inc. (SYBX), as the collapse of the biotech ecosystem and the liquidation of assets make it impossible to restore the profitability of the core business.